relative to the use of psychedelics for therapeutic purposes.

This bill would create a new legal framework in New Hampshire allowing the therapeutic use of specific psychedelics, such as psilocybin, LSD, and mescaline, for patients with certain mental health conditions and chronic pain. It establishes a regulated system where not-for-profit alternative treatment centers can cultivate and distribute these substances to qualifying patients under the supervision of licensed medical providers. The legislation defines strict eligibility criteria for patients, including a list of treatable conditions like anxiety, depression, and PTSD, while also outlining roles for designated caregivers and facility staff. To protect users, the bill provides immunity from arrest and prosecution for patients and caregivers who possess and use these substances within the limits set by the program.